Evidence map›Paper›PMID 37355022›Full record

ReviewThe ocular surface2023

Small leucine rich proteoglycans: Biology, function and their therapeutic potential in the ocular surface.

Tarsis Ferreira Gesteira, Sudhir Verma, Vivien J Coulson-Thomas

Open access · greenAbstract readReview
In one paragraph

Review in The ocular surface, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Biglycan promotes tumour proliferation and invasion in human colon cancers.The Journal of international medical research · 2024
    Article
  16. Article
  17. Biomimetic strategies for the deputization of proteoglycan functions.Frontiers in cell and developmental biology · 2024
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Tarsis Ferreira GesteiraCollege of Optometry, University of Houston, USA. Electronic address: tgferrei@Central.UH.EDU.
Sudhir VermaCollege of Optometry, University of Houston, USA; Department of Zoology, Deen Dayal Upadhyaya College, University of Delhi, Delhi, India.
Vivien J Coulson-ThomasCollege of Optometry, University of Houston, USA. Electronic address: vjcoulso@Central.UH.EDU.
University of Houston · US

Funding

Hyaluronan in the limbal stem cell niche: from regulation of stem cell fate to translational applicationsR01EY029289 · NEI · UNIVERSITY OF HOUSTON · PI Vivien Jane Coulson-Thomas · 2018 to 2026
$3.0M
Modifying the extracellular matrix to prevent dry eye disease and age-related Meibomian gland dysfunction (ARMGD)R01EY033024 · NEI · UNIVERSITY OF HOUSTON · PI COULSON-THOMAS, VIVIEN JANE · 2022 to 2025
$1.6M
NEI NIH HHS R01 EY029289NEI NIH HHS R01 EY033024
6 · The paper itself

Abstract

Small leucine rich proteoglycans (SLRPs) are the largest family of proteoglycans, with 18 members that are subdivided into five classes. SLRPs are small in size and can be present in tissues as glycosylated and non-glycosylated proteins, and the most studied SLRPs include decorin, biglycan, lumican, keratocan and fibromodulin. SLRPs specifically bind to collagen fibrils, regulating collagen fibrillogenesis and the biomechanical properties of tissues, and are expressed at particularly high levels in fibrous tissues, such as the cornea. However, SLRPs are also very active components of the ECM, interacting with numerous growth factors, cytokines and cell surface receptors. Therefore, SLRPs regulate major cellular processes and have a central role in major fundamental biological processes, such as maintaining corneal homeostasis and transparency and regulating corneal wound healing. Over the years, mutations and/or altered expression of SLRPs have been associated with various corneal diseases, such as congenital stromal corneal dystrophy and cornea plana. Recently, there has been great interest in harnessing the various functions of SLRPs for therapeutic purposes. In this comprehensive review, we describe the structural features and the related functions of SLRPs, and how these affect the therapeutic potential of SLRPs, with special emphasis on the use of SLRPs for treating ocular surface pathologies.

Indexed as

Chondroitin Sulfate ProteoglycansExtracellular Matrix ProteinsBiologyCollagenDecorinKeratan SulfateSmall Leucine-Rich ProteoglycansChondroitin Sulfate ProteoglycansCollagenDecorinExtracellular Matrix ProteinsKeratan SulfateSmall Leucine-Rich Proteoglycans

Identifiers

PMID37355022
PMCPMC11092928
OpenAlexW4381620587

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.